Association between brain and skull marrow metabolism in Parkinson's disease: Insights into brain-skull marrow crosstalk.
Association between brain and skull marrow metabolism in Parkinson's disease: Insights into brain-skull marrow crosstalk.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Beijing, CN · Author affiliation
Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Xuanwu Hospital, Beijing 100053, China; Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing 100053, China.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
OBJECTIVES: Parkinson's disease (PD) exhibited abnormalities in skull marrow metabolism. However, the relationship between abnormal skull marrow metabolism and PD-related brain metabolic alterations remains unknown. This study aimed to investigate the relationship between brain metabolic changes and aberrant skull marrow metabolisms in PD. METHODS: 18F-fluorodeoxyglucose positron emission tomography images were acquired from 34 healthy controls (HCs), 32 prodromal PD (pPD), 50 de novo PD (dnPD) and 74 medicated PD (mPD) patients. Expression scores of PD-related patterns (PDRP) and skull marrow glucose metabolic profiles were extracted. Comparisons of glucose uptake in the brain and skull marrow was assessed among groups. The associations between brain and skull marrow glucose metabolism were also evaluated. Furthermore, cross-correlation and Granger causal analysis was used to assess the probable ordering between brain and skull marrow glucose metabolisms across different stages of PD. RESULTS: dnPD and mPD patients exhibited elevated PDRP expression compared to HCs (p < 0.001). Similarly, clinically-confirmed PD patients experienced skull marrow hypermetabolism compared to HCs (p ≤ 0.014). PDRP and cranial glucose metabolisms showed significant associations (r = 0.15-0.17, p = 0.021-0.046). In addition, cross-correlation analysis revealed significant positive lags for the peak correlation coefficients between PDRP and skull marrow metabolisms (p < 0.05). Granger causal analysis revealed significant positive causal projections from PDRP to skull marrow metabolisms (Granger causality coefficient = 0.314-0.344, p ≤ 0.001). INTERPRETATION: This study showed the associations between brain and skull marrow glucose metabolism in different stages of PD, which suggested brain-skull marrow signaling in PD, likely involving neuroimmune crosstalk at the brain-skull interface.